Although both are associated with weight loss, they are not approved as weight loss drugs
At Klinic, we prioritize branded, FDA-approved medications like Wegovy, ensuring superior quality control, consistent dosing, and reliable clinical outcomes, as opposed to compounded alternatives
Early Warning Signs Of Rebound Hunger Or Fatigue One of the biggest risks of stopping GLP-1s abruptly is the sudden return of intense hunger and other withdrawal symptoms
It sounds a cautionary note for short-term use without a more comprehensive approach to weight management. Overeating far more likely Adam Collins, associate professor of nutrition at the University of Surrey in England, who was not involved in the study, called the paper timely and important. Collins underlined that weight regain is a common issue in all weight loss interventions, but the paper shows that this problem is amplified with GLP-1 medications